Germline mutations in BAP1, a bona fide tumor suppressor, are associated with BAP1 tumor predisposition syndrome that puts carriers at a higher risk for several cancer types including uveal melanoma, malignant mesothelioma, clear cell renal cell carcinoma, and basal cell carcinoma [185]. This evidence concerns the gene BAP1 and clear cell renal carcinoma.